A slew trail of
significant movement in STERIS plc's $STE
investment environment has been observed. There has been notable
stake reductions and
increases by investment firms including Findlay Park Partners, Andra AP fonden, and Intech Investment Management. Other firms like JPMorgan Chase & Co., Vanguard Group Inc., and PNC Financial Services Group revealed large holdings in STERIS. Analyst consensus rates the company as a '
Moderate Buy'. Meanwhile, despite meeting Q3 earnings and beating revenue estimates, the stock has dipped in aftermarket trading. There's notable
revenue growth and an improved
margin for the Q2 and Q3 2026 earnings. Despite challenges related to tariffs,
profit climb is reported in the Q3. Other insights include strong
EPS despite mild
revenue miss, and circumstances that entice considerations to add STERIS stock to portfolios. Finally, STERIS plc announced a quarterly
dividend payout of $0.63 payable in March.
Steris Plc STE News Analytics from Thu, 15 May 2025 07:00:00 GMT to Sat, 28 Feb 2026 12:32:57 GMT -
Rating 6
- Innovation 5
- Information 8
- Rumor -4
